Clinical Trial Update: Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction [Phase 1]

View source ↗

Summary

This Phase 1 trial update evaluates TRV120027's renal pharmacodynamics in patients with heart failure and renal dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• TRV120027

Snippet

Sponsor: Trevena Inc. | Conditions: Heart Failure, Kidney Disease | Phase 1 | Status: COMPLETED